Insmed Inc
INSMHealthcare|Biotechnology|USA
$115.61
-2.65 (-2.24%)
Tangible Book
$2.19
Upcoming Data Readouts (6)
Dec 2026
Est. completion
P2P3Pulmonary Arterial Hypertension
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
NCT05649748n=91
Jan 2028
Est. completion
P1Duchenne Muscular Dystrophy
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
NCT06817382n=12
Dec 2028
Est. completion
P3Pulmonary Arterial Hypertension
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
NCT07481981n=344
Dec 2028
Est. completion
P3Pulmonary Hypertension
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07179380n=344
Mar 2030
Est. completion
P1Amyotrophic Lateral Sclerosis
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT07290062n=23
Jan 2050
Est. completion